Premium Information is available for this item - Upgrade for $1 a day
6505-01-304-7219
Octreotide Acetate Injection
6505013047219 013047219 SANDOSTATIN SANDOSTATION INJECTION NDC00078-0182-03
Managed by United States
NSN Created on 26 Jul 1989
Data Last Changed
November 2023
November 2023
NATO Update Count
6
6
NATO Data Quality
Marketplace 6505-01-304-7219
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-304-7219 5+ Documents (More...)
SANDOSTATIN SANDOSTATION INJECTION NDC00078-0182-03 Managed by United States NSN Created on 26 Jul 1989
RQST NE Updated Every Day 6505-01-304-7219 RQST Updated Every Day 6505-01-304-7219 RQST NE Related Documents
6505-01-304-7219 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-304-7219
RQST NE Updated Every Day 6505-01-304-7219 RQST Updated Every Day 6505-01-304-7219 RQST NE Related Documents
6505-01-304-7219 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-304-7219
JavaScript in your web browser . 6505-99-573-5675Octreotide Acetate Injection6505995735675 995735675 SANDOSTATIN
www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-573-5675 Octreotide Acetate Injection 6505995735675 SANDOSTATIN
517-1240 https 6505270040312 https 6505995735675 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-304-7219
www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-573-5675 Octreotide Acetate Injection 6505995735675 SANDOSTATIN
517-1240 https 6505270040312 https 6505995735675 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-304-7219
JavaScript in your web browser . 6505-99-474-4869Octreotide Acetate Injection6505994744869 994744869 SANDOSTATIN
Octreotide Acetate Injection 6505013047219 Octreotide Acetate Injection 6505994744869 JavaScript
in your web browser . 6505-99-474-4869Octreotide Acetate Injection6505994744869 994744869 SANDOSTATIN
Octreotide Acetate Injection 6505013047219 Octreotide Acetate Injection 6505994744869 JavaScript
in your web browser . 6505-99-474-4869Octreotide Acetate Injection6505994744869 994744869 SANDOSTATIN
Upgrade your Account Upgrade 6505-01-304-7220Octreotide Acetate Injection6505013047220 013047220 SANDOSTATIN
Octreotide Acetate Injection 6505013047219 Upgrade your Account Upgrade 6505-01-304-7219Octreotide
Acetate Injection6505013047219 013047219 SANDOSTATIN LAR 013047221 SANDOSTATIN 190028991 304-7219 6505
Octreotide Acetate Injection 6505013047219 Upgrade your Account Upgrade 6505-01-304-7219Octreotide
Acetate Injection6505013047219 013047219 SANDOSTATIN LAR 013047221 SANDOSTATIN 190028991 304-7219 6505
JavaScript in your web browser . 6505-19-002-8991Octreotide Acetate Injection6505190028991 190028991 SANDOSTATIN
Octreotide Acetate Injection 6505270040313 Octreotide Acetate Injection 6505190028991190028991 SANDOSTATIN
013047221 SANDOSTATIN 6505190028991 web browser https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01
Octreotide Acetate Injection 6505270040313 Octreotide Acetate Injection 6505190028991190028991 SANDOSTATIN
013047221 SANDOSTATIN 6505190028991 web browser https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01
Restrictions 6505-01-304-7219
6505-01-304-7219 is a Octreotide Acetate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Approved Sources 6505-01-304-7219
- Part Number
- Manufacturer
- Status
- NDC00078-0182-03
- Manufacturer
- 04520 - Novartis Pharmaceuticals Corporation (Active)
- Primary Buy
- Primary Buy
- SANDOSTATIN
- 04520 - Novartis Pharmaceuticals Corporation (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- SANDOSTATION INJECTION
- 04520 - Novartis Pharmaceuticals Corporation (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Management Data 6505-01-304-7219
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Dec 1999
- Department of the Navy (DN)
- PG
- Subscribe
- 1
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Department of the Navy (DN)
- N
- K
- U/I Contains 20 Ea
- 00000000020EA
- K
- Department of the Navy (DN)
- N
- V
- Discontinued Without Replacement
- V
Army
- Materiel Category and Inventory Manager:
- C
- Medical/Dental Materiel
- Appropriation and Budget Activity:
- 2
- Stock Fund Secondary Items
- Management Inventory Segment:
- 2
- Non-Repairable Items(Exclusive of Insurance and Provisioning Items)
This code will be used to identify items, which are not reparable.
- Weapons System / End Item / Homogeneous Group:
- 01
- DLA/GSA Material
Type 1 (Non-Extendable) Potency Dated Item
- Accounting Requirements:
- X
- Expendable item.An item of Army property coded with an ARC of X in the AMDF. Expendable items require no formal accountability after issue from a stock record account.Commercial and fabricated items similar to items coded X in the AMDF are considered expendable items.
Navy
- Cognizance:
- 9L
NATO Stock Numbers Related to 6505-01-304-7219
6505-27-004-0312 6505-01-304-7220 6505-01-304-7219 6505-99-573-5675 6505-01-304-7218 6505-99-957-9625 6505-99-474-4869 6505-27-004-0313 6505-19-002-8991 6505-01-304-7217 6505-01-304-7221 6505-99-898-8277 6505-01-304-7216 6505-14-517-1235 6505-14-517-1237 6505-99-578-3938 6505-14-517-1240 6505-99-898-7976